Actinium Pharmaceuticals Inc (ATNM) — Cash Flow Reinvestment Rate
Actinium Pharmaceuticals Inc (ATNM) has a Cash Flow Reinvestment Rate of 0.02x as of June 2022, reinvesting $540.00K (capex $270.00K plus investments $-270.00K) from operating cash flow of $27.92 Million. See ATNM FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Actinium Pharmaceuticals Inc Cash Flow Reinvestment Rate (2010–2022)
Historical reinvestment intensity for Actinium Pharmaceuticals Inc across 3 annual periods. For the full cash flow conversion analysis, see Actinium Pharmaceuticals Inc cash flow conversion.
Annual Cash Flow Reinvestment Rate for Actinium Pharmaceuticals Inc (2010–2022)
Year-by-year capital reinvestment analysis for Actinium Pharmaceuticals Inc. See Actinium Pharmaceuticals Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.08x | $732.00K | $8.64 Million | $366.00K | — |
| 2011 | 0.00x | $0.00 | $539.00 | $0.00 | — |
| 2010 | 0.00x | $0.00 | $7.83K | $0.00 | — |